{"entity":{"type":"insider","cik":"0001488919","url":"/insider/0001488919","json_url":"/insider/0001488919.json","name":"Shaffer James P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2012-11-14","last":"2016-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Shaffer James P","source":"filing","n_filings":4,"first_seen":"2012-11-14","last_seen":"2016-08-19"}],"transactions":[{"id":3211958,"accession":"0001209191-16-138022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-138022","line_url":"/filing/0001209191-16-138022#line-1","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001488919","owner_name":"Shaffer James P","owner_display_name":"Shaffer James P","owner_url":"/insider/0001488919","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3125.0,"shares_display":"3,125","price_per_share":15.7,"price_display":"15.70","price_state":"stated","total_value":49062.5,"total_display":"49,062.50","total_whole":"49,063","shares_owned_after":5620.0,"shares_owned_after_display":"5,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-18","filed_date":"2016-08-19","scope":"insider"},{"id":2249785,"accession":"0001209191-16-127845","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-127845","line_url":"/filing/0001209191-16-127845","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001488919","owner_name":"Shaffer James P","owner_display_name":"Shaffer James P","owner_url":"/insider/0001488919","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":22.17424,"price_display":"22.17","price_state":"stated","total_value":27717.8,"total_display":"27,717.80","total_whole":"27,718","shares_owned_after":1975.0,"shares_owned_after_display":"1,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-13","filed_date":"2016-06-14","scope":"insider","n_lines":3},{"id":2699509,"accession":"0001209191-16-122738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-122738","line_url":"/filing/0001209191-16-122738#line-2","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001488919","owner_name":"Shaffer James P","owner_display_name":"Shaffer James P","owner_url":"/insider/0001488919","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":745.0,"shares_display":"745","price_per_share":19.99,"price_display":"19.99","price_state":"stated","total_value":14892.55,"total_display":"14,892.55","total_whole":"14,893","shares_owned_after":1245.0,"shares_owned_after_display":"1,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-23","scope":"insider"},{"id":2699502,"accession":"0001209191-16-122738","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-122738","line_url":"/filing/0001209191-16-122738#line-1","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001488919","owner_name":"Shaffer James P","owner_display_name":"Shaffer James P","owner_url":"/insider/0001488919","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":19.52,"price_display":"19.52","price_state":"stated","total_value":9760.0,"total_display":"9,760.00","total_whole":"9,760","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-19","filed_date":"2016-05-23","scope":"insider"},{"id":3098574,"accession":"0001483813-12-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001483813-12-000031","line_url":"/filing/0001483813-12-000031#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS INC","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001488919","owner_name":"Shaffer James P","owner_display_name":"Shaffer James P","owner_url":"/insider/0001488919","role":"Officer (VP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (VP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":104400.0,"total_display":"104,400.00","total_whole":"104,400","shares_owned_after":26300.0,"shares_owned_after_display":"26,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-14","filed_date":"2012-11-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001305253","name":"Eiger BioPharmaceuticals, Inc.","url":"/issuer/0001305253","role":"Officer (Chief Business Officer)","n_filings":3,"first_seen":"2016-05-23","last_seen":"2016-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS INC","url":"/issuer/0001159036","role":"Officer (VP & Chief Commercial Officer)","n_filings":1,"first_seen":"2012-11-14","last_seen":"2012-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001488919","retrieved_at":"2026-08-23T13:38:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}